PATENT CLAIM ANALYSIS

Application Number: 15944072
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "277100"]

Abstract:
The present invention relates to a method for the preparation of an immunogenic lysate from mesothelioma tumor cells, to such a lysate and to dendritic cells loaded with the lysate, the present invention further relates a pharmaceutical composition comprising such lysate or dendritic cells, to the use of the lysate, and to said loaded dendritic cells or said pharmaceutical composition for use in the prevention or treatment of mesothelioma.

Claim (Index 46):
The immunogenic lysate according to  claim 45 , wherein at least one of the tumor cell lines has been derived from a tumor tissue specimen with an immune contexture having\n (a) more than 500 CD3 +  cells per mm 2 ; (b) more than 200 CD45RO +  cells per mm 2 ; (c) less than 50 FoxP3 +  cells per mm 2 ; and (d) less than 1000 CD206 +  cells per mm 2 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.11429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14758153', '10524738', '14247028', '10495511', '12995434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6937676937771671
- 35 USC 102 Novelty (BERT): 0.5547466754644348
- Combined Prediction Score: 0.6798655919458939
- Mean Citation Score: 257.38111200000003
- Max Citation Score: 397.9841
- Similarity Product: 360.6659029496253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test